Author

D.J. Kereiakes

Observed names: D. J. Kereiakes, D. Kereiakes, Dean J Kereiakes

Institution: Christ Hospital

Observed institutions: Deakin University, Centre Hospitalier Universitaire de Grenoble, Christ Hospital

OpenAlex ID: A5110614893

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

2023 · Truman J. Milling, Saskia Middeldorp, et al. · Circulation · 174

Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure

2017 · Milton Packer, John J.V. McMurray, et al. · JACC Heart Failure · 133

Results of intracoronary recombinant human vascular endothelial growth factor (rhVEGF) administration trial

1998 · T.D. Henry, K. Rocha-Singh, et al. · Journal of the American College of Cardiology · 46

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs. heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

2004 · A.M. Lincoff, N.S. Kleiman, et al. · ACC Current Journal Review · 19

Usefulness of a cobalt chromium coronary stent alloy

2003 · D.J. Kereiakes, D.A. Cox, et al. · ACC Current Journal Review · 17

Sustained platelet GP IIb/IIIa blockade with oral orbofiban: interim phamacodynamic results of the SOAR study

1998 · J.J. Ferguson, P.C. Deedwania, et al. · Journal of the American College of Cardiology · 12

Two-Year Outcomes With the Absorb Bioresorbable Scaffold for Treatment of Coronary Artery Disease: A Systematic Review and Meta-Analysis of Seven Randomized Trials With an Individual Patient Data Substudy

2017 · Z.A. Ali, P.W. Serruys, et al. · Journal of Vascular Surgery · 5

Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trial

2026 · Eliano P Navarese, Giuseppe Talanas, et al. · European Journal of Preventive Cardiology · 2

Abciximab markedly reduces 30-day adverse outcomes in black patients undergoing coronary intervention

1999 · Marks Ds, Mark B. Effron, et al. · Circulation · 1

Effect of J-Valve on Left Ventricular (LV) Ejection Fraction (EF) and LV Geometry: A Multi-Center Compassionate Use Study in Patients With Aortic Regurgitation

2024 · H. Bashir, S. Garcia, et al. · Cardiovascular revascularization medicine

800.05 Effect of J-Valve on Left Ventricular (LV) Ejection Fraction (EF) and LV Geometry: A Multi-Center Compassionate Use Study in Patients With Aortic Regurgitation

2024 · H. Bashir, S. Garcia, et al. · JACC: Cardiovascular Interventions

BASKET-PROVE II: BP-DES Noninferior to DP-DES

2014 · B. Hoyle, D. J. Kereiakes · MD Conference Express

SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial

2014 · B. Hoyle, D. J. Kereiakes · MD Conference Express

Plasma procarboxypeptidase U is up-regulated in patients undergoing percutaneous intervention: effects of anticoagulant dosage of low molecular weight heparins

2003 · M. Florian-Kujawski, D. A. Hoppensteadt, et al. · Journal of Thrombosis and Haemostasis

Abciximab associated thrombocytopenia: evidence for a complex interaction with heparin

1998 · D.J. Kereiakes, S.D. Berkowitz, et al. · Journal of the American College of Cardiology

Works count: 15

Citation count: 409

H-index: 6

I10-index: 6